This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human ST2/IL-33R Quantikine ELISA Kit
catalog :
DST200
quantity :
1 Kit
price :
655 USD
citations: 38
Reference
Arakélian L, Lion J, Churlaud G, Bargui R, Thierry B, Mutabazi E, et al. Endothelial CD34 expression and regulation of immune cell response in-vitro. Sci Rep. 2023;13:13512 pubmed publisher
Gherghe M, Lazar A, Mutuleanu M, Bordea C, Ionescu S, Mihaila R, et al. Evaluating Cardiotoxicity in Breast Cancer Patients Treated with HER2 Inhibitors: Could a Combination of Radionuclide Ventriculography and Cardiac Biomarkers Predict the Cardiac Impact?. Cancers (Basel). 2022;15: pubmed publisher
Pal xe0 E, Bustamante A, Cl xfa a Espuny J, Acosta J, Gonz xe1 lez Loyola F, Santos S, et al. Blood-biomarkers and devices for atrial fibrillation screening: Lessons learned from the AFRICAT (Atrial Fibrillation Research In CATalonia) study. PLoS ONE. 2022;17:e0273571 pubmed publisher
Luther J, Vannier A, Schaefer E, Goodman R. The circulating proteomic signature of alcohol-associated liver disease. JCI Insight. 2022;7: pubmed publisher
Simeone P, Tripaldi R, Michelsen A, Ueland T, Liani R, Ciotti S, et al. Effects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss. Cardiovasc Diabetol. 2022;21:36 pubmed publisher
Mai E, Chan J, Goon L, Ego B, Bevers J, Wong T, et al. Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development. J Transl Med. 2021;19:517 pubmed publisher
Su Y, Sun Y, Tang Y, Li H, Wang X, Pan X, et al. Circulating miR-19b-3p as a Novel Prognostic Biomarker for Acute Heart Failure. J Am Heart Assoc. 2021;10:e022304 pubmed publisher
Ambari A, Setianto B, Santoso A, Radi B, Dwiputra B, Susilowati E, et al. Randomised controlled trial into the role of ramipril in fibrosis reduction in rheumatic heart disease: the RamiRHeD trial protocol. BMJ Open. 2021;11:e048016 pubmed publisher
Yao Y, Feng L, Sun Y, Wang S, Sun J, Hu B. Myocardial fibrosis combined with NT-proBNP improves the accuracy of survival prediction in ADHF patients. BMC Cardiovasc Disord. 2021;21:264 pubmed publisher
Cyr A, Zhong Y, Reis S, Namas R, Amoscato A, Zuckerbraun B, et al. Analysis of the Plasma Metabolome after Trauma, Novel Circulating Sphingolipid Signatures, and In-Hospital Outcomes. J Am Coll Surg. 2021;232:276-287.e1 pubmed publisher
Hannappe M, Arnould L, Meloux A, Mouhat B, Bichat F, Zeller M, et al. Vascular density with optical coherence tomography angiography and systemic biomarkers in low and high cardiovascular risk patients. Sci Rep. 2020;10:16718 pubmed publisher
Kowalik E, Kwiatek Wrzosek A, Klisiewicz A, Lutynska A, Biernacka E, Kowalski M, et al. Systemic right ventricle in elderly patients with congenitally corrected transposition of the great arteries: Clinical profile, cardiac biomarkers, and echocardiographic parameters. Anatol J Cardiol. 2020;24:92-96 pubmed publisher
Saresella M, Marventano I, Piancone F, La Rosa F, Galimberti D, Fenoglio C, et al. IL-33 and its decoy sST2 in patients with Alzheimer's disease and mild cognitive impairment. J Neuroinflammation. 2020;17:174 pubmed publisher
Abhyankar M, Ma J, Scully K, Nafziger A, Frisbee A, Saleh M, et al. Immune Profiling To Predict Outcome of Clostridioides difficile Infection. MBio. 2020;11: pubmed publisher
Scurt F, Menne J, Brandt S, Bernhardt A, Mertens P, Haller H, et al. Systemic Inflammation Precedes Microalbuminuria in Diabetes. Kidney Int Rep. 2019;4:1373-1386 pubmed publisher
Yin X, Cao H, Wei Y, Li H. Alteration of the IL-33-sST2 pathway in hypertensive patients and a mouse model. Hypertens Res. 2019;: pubmed publisher
Frisbee A, Saleh M, Young M, Leslie J, Simpson M, Abhyankar M, et al. IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection. Nat Commun. 2019;10:2712 pubmed publisher
Almahmoud K, Abboud A, Namas R, Zamora R, Sperry J, Peitzman A, et al. Computational evidence for an early, amplified systemic inflammation program in polytrauma patients with severe extremity injuries. PLoS ONE. 2019;14:e0217577 pubmed publisher
Ohta N, Yasudo H, Mizutani M, Matsushige T, Fukano R, Kittaka S, et al. Serum soluble ST2 as a marker of renal scar in pediatric upper urinary tract infection. Cytokine. 2019;120:258-263 pubmed publisher
Wu C, Su M, Wu Y, Hwang J, Lin L. Combination of Plasma Biomarkers and Clinical Data for the Detection of Myocardial Fibrosis or Aggravation of Heart Failure Symptoms in Heart Failure with Preserved Ejection Fraction Patients. J Clin Med. 2018;7: pubmed publisher
Lepojärvi E, Huikuri H, Piira O, Kiviniemi A, Miettinen J, Kenttä T, et al. Biomarkers as predictors of sudden cardiac death in coronary artery disease patients with preserved left ventricular function (ARTEMIS study). PLoS ONE. 2018;13:e0203363 pubmed publisher
Watanabe M, Nakamoto K, Inui T, Sada M, Honda K, Tamura M, et al. Serum sST2 levels predict severe exacerbation of asthma. Respir Res. 2018;19:169 pubmed publisher
Wei Z, Li Y, Huang S, Tan Z. Genetic variants in IL-33/ST2 pathway with the susceptibility to hepatocellular carcinoma in a Chinese population. Cytokine. 2018;: pubmed publisher
Binas D, Daniel H, Richter A, Ruppert V, Schluter K, Schieffer B, et al. The prognostic value of sST2 and galectin-3 considering different aetiologies in non-ischaemic heart failure. Open Heart. 2018;5:e000750 pubmed publisher
Dijk F, Xu C, Melen E, Carsin A, Kumar A, Nolte I, et al. Genetic regulation of IL1RL1 methylation and IL1RL1-a protein levels in asthma. Eur Respir J. 2018;51: pubmed publisher
Miller J, Monsanto S, Ahn S, Khalaj K, Fazleabas A, Young S, et al. Interleukin-33 modulates inflammation in endometriosis. Sci Rep. 2017;7:17903 pubmed publisher
Rotz S, Dandoy C, Taylor M, Jodele S, Jefferies J, Lane A, et al. Long-term systolic function in children and young adults after hematopoietic stem cell transplant. Bone Marrow Transplant. 2017;52:1443-1447 pubmed publisher
Younas M, Psomas C, Mehraj V, Cezar R, Portales P, Tuaillon E, et al. Plasma Level of Soluble ST2 in Chronically Infected HIV-1 Patients with Suppressed Viremia. Open AIDS J. 2017;11:32-35 pubmed publisher
Rotz S, Ryan T, Jodele S, Jefferies J, Lane A, Pate A, et al. The injured heart: early cardiac effects of hematopoietic stem cell transplantation in children and young adults. Bone Marrow Transplant. 2017;52:1171-1179 pubmed publisher
Wojciechowska C, Romuk E, Nowalany Kozielska E, Jachec W. Serum Galectin-3 and ST2 as predictors of unfavorable outcome in stable dilated cardiomyopathy patients. Hellenic J Cardiol. 2017;58:350-359 pubmed publisher
Yang J, Savvatis K, Kang J, Fan P, Zhong H, Schwartz K, et al. Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment. Nat Commun. 2016;7:13710 pubmed publisher
Shen J, Shang Q, Wong C, Li E, Kun E, Cheng I, et al. Carotid plaque and bone density and microarchitecture in psoriatic arthritis: the correlation with soluble ST2. Sci Rep. 2016;6:32116 pubmed publisher
Fu A, Hung K, Yuen M, Zhou X, Mak D, Chan I, et al. IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline. Proc Natl Acad Sci U S A. 2016;113:E2705-13 pubmed publisher
Sun M, Ma H, Che Y, Cui X. Reduced IL-33 plasma levels in aplastic anemia. Cancer Cell Int. 2015;15:118 pubmed publisher
Traister R, Uvalle C, Hawkins G, Meyers D, Bleecker E, Wenzel S. Phenotypic and genotypic association of epithelial IL1RL1 to human TH2-like asthma. J Allergy Clin Immunol. 2015;135:92-9 pubmed publisher
Faber T, Schuurhof A, Vonk A, Koppelman G, Hennus M, Kimpen J, et al. IL1RL1 gene variants and nasopharyngeal IL1RL-a levels are associated with severe RSV bronchiolitis: a multicenter cohort study. PLoS ONE. 2012;7:e34364 pubmed publisher
Miyagaki T, Sugaya M, Yokobayashi H, Kato T, Ohmatsu H, Fujita H, et al. High levels of soluble ST2 and low levels of IL-33 in sera of patients with HIV infection. J Invest Dermatol. 2011;131:794-6 pubmed publisher
Yagami A, Orihara K, Morita H, Futamura K, Hashimoto N, Matsumoto K, et al. IL-33 mediates inflammatory responses in human lung tissue cells. J Immunol. 2010;185:5743-50 pubmed publisher
product information
master code :
DST200
SKU :
DST200
product name :
Human ST2/IL-33R Quantikine ELISA Kit
unit size :
1 Kit
description :
The Human ST2/IL-33R Quantikine ELISA Kit from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human ST2/IL-33R in cell culture supernates (50 ul), serum (10 ul), edta plasma (10 ul), heparin plasma (10 ul).
target :
ST2/IL-33R
category :
ELISAs
species :
Human
specificity :
Natural and recombinant human ST2 as well as free ST2 and IL-33 complexed ST2
gene symbol :
IL1RL1
kit type :
Solid Phase Sandwich ELISA
assay length :
4.5 hours
elisaSampleTypes :
Cell Culture Supernates (50 uL), Serum (10 uL), EDTA Plasma (10 uL), Heparin Plasma (10 uL)
elisaSensitivity :
13.5 pg/mL
elisaRange :
31.30 - 2000 pg/mL
top caption :
Human ST2/IL-1 R4 ELISA Standard Curve
applications :
ELISA
USD :
655 USD
product details :
The Quantikine Human ST2/IL-33 R Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human ST2 in cell culture supernates, serum, and plasma. It contains NS0-expressed recombinant human ST2 and has been shown to accurately quantitate the recombinant factor. Results obtained using natural human ST2 showed linear curves that were parallel to the standard curves obtained using the Quantikine kit standards. These results indicate that this kit can be used to determine relative mass values for naturally occurring ST2.
alt names :
DER4, DER4ST2growth stimulation-expressed, FIT-1, IL-1 R4, IL1R4, IL-1R4, IL-1RL1, IL-33 R, IL33R, IL-33R, interleukin 1 receptor-like 1, interleukin 1 receptor-related protein, interleukin-1 receptor-like 1, Ly84, MGC32623, Protein ST2, ST2L, ST2V, T1, T1homolog of mouse growth stimulation-expressed
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.